Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
Human Mutation|September 17, 2016
BRCA Share: A Collection of Clinical BRCA Gene VariantsChristophe Béroud, Stanley I Letovsky, Corey D Braastad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotypeSunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, et al.
International Journal of Cancer|December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2002
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage ConsortiumDeborah Thompson, Csilla I Szabo, Jon Mangion, et al.
Cancers|August 7, 2021
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel TestingFabienne Lesueur, Séverine Eon-Marchais, Sarah Bonnet-Boissinot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
International Journal of Cancer|October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testingElodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
Breast Cancer Research and Treatment|July 24, 2010
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationAna Peixoto, Catarina Santos, Manuela Pinheiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.
Pageof 24